Literature DB >> 17029272

Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations.

Hideaki Matsui1, Kazuto Nishinaka, Masaya Oda, Narihiro Hara, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka.   

Abstract

Little is known about the developing mechanisms of visual hallucinations in Parkinson's disease. This study aimed to investigate perfusion changes in parkinsonian patients with visual hallucinations using n-isopropyl-p-[123I]iodoamphetamine ([123I]IMP) single photon emission computed tomography imaging. A total of 70 consecutive patients, including 31 patients with visual hallucinations, and 39 patients without hallucinations, participated in this study. Patients with severe cognitive impairment (Mini-Mental State Examination score < 20), nonvisual hallucinations, or confusion were excluded. We compared brain perfusion changes between the two groups. We found that hallucinatory patients had significant perfusion reductions in the bilateral inferior parietal lobule, inferior temporal gyrus, precuneus gyrus, and occipital cortex compared to nonhallucinatory patients. These results suggested that hypoperfusion of the visual pathway was closely related to visual hallucinations in Parkinson's disease. Copyright 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029272     DOI: 10.1002/mds.21140

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

Review 1.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

Review 2.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

3.  Multi-modal hallucinations and cognitive function in Parkinson's disease.

Authors:  Heather Katzen; Connie Myerson; Spiridon Papapetropoulos; Fatta Nahab; Bruno Gallo; Bonnie Levin
Journal:  Dement Geriatr Cogn Disord       Date:  2010-07-31       Impact factor: 2.959

4.  Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.

Authors:  Stephanie C Licata; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-30       Impact factor: 5.067

5.  Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Vy Dinh; Bryan Bernard; Doug Merkitch; Leyla deToledo-Morrell; Christopher G Goetz
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

Review 6.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

7.  Increasing Contrast Improves Object Perception in Parkinson's Disease with Visual Hallucinations.

Authors:  Mirella Díaz-Santos; Zachary A Monge; Robert D Salazar; Grover C Gilmore; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Mov Disord Clin Pract       Date:  2020-11-17

8.  New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges.

Authors:  Jennifer G Goldman
Journal:  Parkinsons Dis       Date:  2011-03-02

Review 9.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

10.  Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.

Authors:  Ahmad A Khundakar; Peter S Hanson; Daniel Erskine; Nichola Z Lax; Joseph Roscamp; Evangelia Karyka; Eliona Tsefou; Preeti Singh; Simon J Cockell; Andrew Gribben; Lynne Ramsay; Peter G Blain; Urs P Mosimann; Deborah J Lett; Matthias Elstner; Douglass M Turnbull; Charles C Xiang; Michael J Brownstein; John T O'Brien; John-Paul Taylor; Johannes Attems; Alan J Thomas; Ian G McKeith; Christopher M Morris
Journal:  Acta Neuropathol Commun       Date:  2016-06-30       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.